MSN Lab's Generic Carmustine Receives Receives Approval in the U.S.
Accord's Generic Carmustine Receives Approval in the U.S.
Ingenus Pharma's Generic Naloxone Hydrochloride Receives Approval in US
HYDERABAD, India & PRINCETON, N.J.--(BUSINESS WIRE)--Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced the launch of Carmustine for Injection, USP, a therapeutic equivalent generic version of BiCNU® (carmustine for injection) approved by the U.S. Food and Drug Administration (USFDA).
Hong Kong BioPharma`s Generic Carmustine Receives Tentative Approval In US
Jiangsu Hengrui’s Generic Carmustine Receives Approval In US
STI Pharmaceuticals Generic Carmustine Receives Approval in US
Amneal’s abbreviated new drug application (ANDA) for Carmustine for injection was the first ANDA to win a priority review – a new designation for generic drugs thanks to the FDA Reauthorization Act of 2017 (FDARA).
Amneal Pharms's Generic Carmustine Receives Approval in US
Navinta LLC's Generic Carmustine Receives Approval in US